TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): Capital Expenditures

Annual figures by period end, from SEC filings.

$15.6K
Year ended 2025-12-31
-82.0%
3-year compound annual growth
-66.7%
5-year compound annual growth
$3.81M2019-12-31: $266.7K2020-12-31: $3.81M2021-12-31: $850.2K2022-12-31: $2.70M2023-12-31: $1.18M2024-12-31: $133.6K2025-12-31: $15.6K$15.6K
2019-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$15.6K-88.3%2026-04-29, From 2025-01-01
2024-12-31$133.6K-88.7%2026-04-29, From 2024-01-01
2023-12-31$1.18M-56.2%2026-04-29, From 2023-01-01
2022-12-31$2.70M+217.4%2025-04-25, From 2022-01-01
2021-12-31$850.2K-77.7%2024-04-24, From 2021-01-01
2020-12-31$3.81Mn/m2023-08-29, From 2020-01-01
2019-12-31$266.7Kn/a2022-07-29, From 2019-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$15.6K-88.3%
LENSAR, Inc. (LNSR)2025-12-31$83.0K-46.8%
CVRx, Inc. (CVRX)2025-12-31$580.0K-57.4%
AVITA Medical, Inc. (RCEL)2025-12-31$1.00M-89.0%
Apyx Medical Corp (APYX)2025-12-31$1.11M+54.3%
Carlsmed, Inc. (CARL)2025-12-31$642.0K+256.7%
Sight Sciences, Inc. (SGHT)2025-12-31$224.0K-41.8%
PRO DEX Inc (PDEX)2026-06-30$483.0K-61.2%
TELA Bio, Inc. (TELA)2025-12-31$448.0K-54.7%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗